Levesia (Ethinylestradiol, Levonorgestrel | Lactose)

The ethinylestradiol component stabilises the endometrial lining, while levonorgestrel suppresses the mid‑cycle LH and FSH surge, preventing ovulation. Together they thicken cervical mucus and alter the uterine lining, reducing the chance of sperm reaching an egg and of implantation.

The dosing regimen for Levesia is determined by the prescribing healthcare professional. Typically, the medication is taken once daily at the same time each day, but the exact schedule should follow the prescriber’s instructions.

Levesia is contraindicated during pregnancy and should not be started in women who are already pregnant. While limited data exist for breastfeeding, the progestin component may affect milk production, and clinicians usually advise caution or alternative methods.

To order Levesia, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levesia contains the standard dose of ethinylestradiol combined with levonorgestrel, a widely used progestin. Its efficacy and safety profile are comparable to other approved combined oral contraceptives, though individual tolerability may vary based on hormone sensitivity and personal health factors.

Levesia tablets should be stored at ambient temperature, preferably below 25 °C, in their original blister pack to protect from moisture and light. Keep the medication out of reach of children and do not use after the expiry date.

Levesia is taken orally as a tablet. The patient should swallow the tablet with water, preferably at the same time each day, and should not skip doses. If a dose is missed, follow the guidance provided by the prescribing clinician.

Serious risks include venous thromboembolism, stroke, and severe allergic reactions such as anaphylaxis. Women with a history of clotting disorders, cardiovascular disease, or certain cancers should be evaluated carefully before using Levesia.

Levesia is not recommended for women who are pregnant, have active thromboembolic disease, uncontrolled hypertension, severe liver disease, known hypersensitivity to any component, or who smoke heavily and are over 35 years of age.